BioReference Laboratories and State of New Jersey provided testing for Coronavirus 2019
On Mar. 20, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the State of New…
-
-
Biotechnology | CDC | COVID-19 | Infectious Disease | NIH
Research revealed new coronavirus stable for hours on surfaces
On Mar. 17, 2020, the virus that causes coronavirus disease 2019 (COVID-19) was stable for several hours to…
-
BD, BioGX announced FDA Emergency Use Authorization submissions for new COVID-19 diagnostics for use in U.S.
On Mar. 16, 2020, BD (Becton, Dickinson and Company) announced the companies had submitted Emergency Use Authorization requests…
-
Johnson & Johnson collaborated with Beth Israel Deaconess Medical Center to accelerate COVID-19 vaccine development
On Mar. 13, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical Companies have entered a collaboration with…
-
CerTest Biotec and BD announced COVID-19 diagnostic test
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
-
OPKO Health introduced Coronavirus disease (COVID-19) test
On Mar. 5, 2020, BioReference Laboratories, an OPKO Health company, announced it was offering a test for the…
-
Tonix Pharma announced collaboration with Southern Research to develop vaccine to protect against COVID-19 based on Horsepox virus
On Feb. 26, 2020, Southern Research announced today that it has entered into a strategic collaboration with New…
-
FDA approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for adults 65 years and older
On Feb. 24, 2020, Seqirus announced that the U.S. Food and Drug Administration (FDA) had approved the first…
-
Sorrento and Celularity to initiate emergency allogeneic natural killer cell therapy development for Coronavirus infection
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
-
Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
-
Abaxis was acquired by Zoetis
On Jul. 31, 2018, Zoetis anounced it had completed the acquisition of Abaxis, a leader in the development,…
-
Teva Pharmaceuticals announced North America headquarters moved to New Jersey
On Jul. 6, 2018, Teva Pharmaceuticals formalized its commitment to consolidate its North America Commercial business areas into…
-
The Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
-
Bristol-Myers Squibb announced closure of Seattle’s ZymoGenetics operation
On Dec. 13, 2016, Bristol-Myers Squibb announced that it would not renew its lease at the Lake Union…
-
BD announced $20 million investment in Sandy, Utah facility
On Aug. 18, 2016, BD (Becton, Dickinson and Company) celebrated the 60th anniversary of its manufacturing facility in…
-
FDA expanded Gardasil 9 licensure to include males age 16-26 years
On Dec. 14, 2015, the U.S. Food and Drug Administration (FDA) announced it had expanded Merck’s Gardasil 9…
-
The Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute
On Oct. 21, 2015, the Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute. The…
-
Stephen J. Elledge and Evelyn M. Witkin received Lasker Award
On Sept. 18, 2015, Stephen J. Elledge from Brigham and Women’s Hospital and Evelyn M. Witkin from Rutgers…
-
Rutgers Cancer Institute of New Jersey was one of seven worldwide sites to offer debulking prostatectomy
On May 5, 2015, Rutgers Cancer Institute of New Jersey was one of seven international sites to offer…
-
Common Pesticide May Increase Risk of ADHD
On Jan. 29, 2015, a Rutgers University study suggests that pregnant women and young children are more susceptible…
-
Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
-
Bristol-Myers Squibb announced plans to build state-of-the-art campus in Lawrenceville
On Sept. 23, 2014, Bristol-Myers Squibb announced plans to build a 650,000-square-foot office building on company-owned land at…
-
Roche announced the closure of the Nutley/Clifton campus
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
-
Zostavax was approved by the FDA to prevent shingles in individuals 50 years of age and older
On Mar. 24, 2011, Zostavax, manufactured by Merck of Whitehouse Station, New Jersey, was approved by the U.S….
-
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
-
Biotechnology | FDA | Vaccine
Zostavax was approved by the FDA to prevent shingles (herpes zoster) in individuals 60 years of age and older
On May 25, 2006, Zostavax, manufactured by Merck & Co. of Whitehouse Station, New Jersey, was approved by…
-
FDA approved lowering the age limit to 12 mos for one of the two licensed hepatitis A vaccine
On Aug. 11, 2005, the Food and Drug Administration (FDA) approved an application of a pediatric/adolescent formulation of…
-
Molecular biologist Shirley M. Tilghman was elected the first woman president of Princeton University
On May 5, 2001, molecular biologist Shirley M. Tilghman was elected the first woman president of Princeton University. An…
-
Scientists Create Smart Mouse
On Sept. 1, 1999, Princeton University researchers reported that they had genetically modified mice to have improved learning…
-
Elizabeth Gould of Princeton University published observations of neurogenesis in the adult brain
In 1998, Elizabeth Gould of Princeton University first reported neurogenesis in an adult primate when she observed that…
